<PAPER>
  <mode2 name="ehp3_arathi" hasDoc="yes" version="1258"/>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="en">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
        <journal-title>Environmental Health Perspectives</journal-title>
        <abbrev-journal-title>Environ Health Perspect</abbrev-journal-title>
        <issn pub-type="epub">0091-6765</issn>
        <publisher>
          <publisher-name>National Institute of Environmental Health Sciences</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="doi">10.1289/ehp.0800119</article-id>
        <article-id pub-id-type="publisher-id">ehp-117-552</article-id>
        <article-categories>
          <subj-group>
            <subject>Research</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>
            <s sid="1">PAH&#8211;DNA Adducts, Cigarette Smoking, <italic>GST</italic> Polymorphisms, and Breast Cancer Risk<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
          </article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>McCarty</surname>
              <given-names>Kathleen M.</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp-117-552">
              <sup>1</sup>
            </xref>
            <xref ref-type="aff" rid="af2-ehp-117-552">
              <sup>2</sup>
            </xref>
            <xref ref-type="corresp" rid="c1-ehp-117-552"/>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Santella</surname>
              <given-names>Regina M.</given-names>
            </name>
            <xref ref-type="aff" rid="af3-ehp-117-552">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Steck</surname>
              <given-names>Susan E.</given-names>
            </name>
            <xref ref-type="aff" rid="af4-ehp-117-552">
              <sup>4</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Cleveland</surname>
              <given-names>Rebecca J.</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp-117-552">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Ahn</surname>
              <given-names>Jiyoung</given-names>
            </name>
            <xref ref-type="aff" rid="af5-ehp-117-552">
              <sup>5</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Ambrosone</surname>
              <given-names>Christine B.</given-names>
            </name>
            <xref ref-type="aff" rid="af6-ehp-117-552">
              <sup>6</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>North</surname>
              <given-names>Kari</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp-117-552">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Sagiv</surname>
              <given-names>Sharon K.</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp-117-552">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Eng</surname>
              <given-names>Sybil M.</given-names>
            </name>
            <xref ref-type="aff" rid="af7-ehp-117-552">
              <sup>7</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Teitelbaum</surname>
              <given-names>Susan L.</given-names>
            </name>
            <xref ref-type="aff" rid="af8-ehp-117-552">
              <sup>8</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Neugut</surname>
              <given-names>Alfred I.</given-names>
            </name>
            <xref ref-type="aff" rid="af9-ehp-117-552">
              <sup>9</sup>
            </xref>
            <xref ref-type="aff" rid="af10-ehp-117-552">
              <sup>10</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Gammon</surname>
              <given-names>Marilie D.</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp-117-552">
              <sup>1</sup>
            </xref>
          </contrib>
        </contrib-group>
        <aff id="af1-ehp-117-552">
          <label>1</label>
          <addr-line>Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA;</addr-line>
        </aff>
        <aff id="af2-ehp-117-552">
          <label>2</label>
          <addr-line>Department of Epidemiology and Public Health, Division of Environmental Health Sciences, School of Medicine, Yale University, New Haven, Connecticut, USA;</addr-line>
        </aff>
        <aff id="af3-ehp-117-552">
          <label>3</label>
          <addr-line>Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, USA;</addr-line>
        </aff>
        <aff id="af4-ehp-117-552">
          <label>4</label>
          <addr-line>Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA;</addr-line>
        </aff>
        <aff id="af5-ehp-117-552">
          <label>5</label>
          <addr-line>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA;</addr-line>
        </aff>
        <aff id="af6-ehp-117-552">
          <label>6</label>
          <addr-line>Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA;</addr-line>
        </aff>
        <aff id="af7-ehp-117-552">
          <label>7</label>
          <addr-line>Epidemiologic Resources, Safety Evaluation, and Epidemiology, Pfizer, Inc., New York, New York, USA;</addr-line>
        </aff>
        <aff id="af8-ehp-117-552">
          <label>8</label>
          <addr-line>Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York, USA;</addr-line>
        </aff>
        <aff id="af9-ehp-117-552">
          <label>9</label>
          <addr-line>Department of Epidemiology, Mailman School of Public Health and</addr-line>
        </aff>
        <aff id="af10-ehp-117-552">
          <label>10</label>
          <addr-line>Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA</addr-line>
        </aff>
        <author-notes>
          <corresp id="c1-ehp-117-552">Address correspondence to K.M. McCarty, Yale University Epidemiology and Public Health, Environmental Health Sciences Division, 60 College St., Room 442, New Haven, CT 06520-8034 USA. Telephone: (203) 785-2880. Fax: (203) 737-6023. E-mail: <email xlink:type="simple">kathleen.mccarty@yale.edu</email></corresp>
          <fn>
            <p>The authors declare they have no competing financial interests.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <month>4</month>
          <year>2009</year>
        </pub-date>
        <pub-date pub-type="epub">
          <day>10</day>
          <month>12</month>
          <year>2008</year>
        </pub-date>
        <volume>117</volume>
        <issue>4</issue>
        <fpage>552</fpage>
        <lpage>558</lpage>
        <history>
          <date date-type="received">
            <day>21</day>
            <month>8</month>
            <year>2008</year>
          </date>
          <date date-type="accepted">
            <day>8</day>
            <month>12</month>
            <year>2008</year>
          </date>
        </history>
        <copyright-statement>This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <abstract>
          <sec>
            <title>Background</title>
            <p>
              <s sid="2">Polycyclic aromatic hydrocarbons (PAHs) may increase breast cancer risk, and the association may be modified by inherited differences in deactivation of PAH intermediates by glutathione <italic>S</italic>-transferases (GSTs).<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/></s>
              <s sid="3">Few breast cancer studies have investigated the joint effects of multiple GSTs and a PAH biomarker.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Objective</title>
            <p>
              <s sid="4">We estimated the breast cancer risk associated with multiple polymorphisms in the <italic>GST</italic> gene (<italic>GSTA1</italic>, <italic>GSTM1</italic>, <italic>GSTP1</italic>, and <italic>GSTT1</italic>) and the interaction with PAH&#8211;DNA adducts and cigarette smoking.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Methods</title>
            <p>
              <s sid="5">We conducted unconditional logistic regression using data from a population-based sample of women (cases/controls, respectively): <italic>GST</italic> polymorphisms were genotyped using polymerase chain reaction and matrix-assisted laser desorption/ionization time-of-flight assays (<italic>n</italic> = 926 of 916), PAH&#8211;DNA adduct blood levels were measured by competitive enzyme-linked immunosorbent assay (<italic>n</italic> = 873 of 941), and smoking status was assessed by in-person questionnaires (<italic>n</italic> = 943 of 973).<CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Results</title>
            <p>
              <s sid="6">Odds ratios for joint effects on breast cancer risk among women with at least three variant alleles were 1.56 [95% confidence interval (CI), 1.13&#8211;2.16] for detectable PAH&#8211;DNA adducts and 0.93 (95% CI, 0.56&#8211;1.56) for no detectable adducts; corresponding odds ratios for three or more variants were 1.18 (95% CI, 0.82&#8211;1.69) for ever smokers and 1.44 (95% CI, 0.97&#8211;2.14) for never smokers.<CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
              <s sid="7">Neither interaction was statistically significant (<italic>p</italic> = 0.43 and 0.62, respectively).<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Conclusion</title>
            <p>
              <s sid="8">We found little statistical evidence that PAHs interacted with <italic>GSTT1</italic>, <italic>GSTM1</italic>, <italic>GSTP1</italic>, and <italic>GSTA1</italic> polymorphisms to further increase breast cancer risk.<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>breast cancer</kwd>
          <kwd>GST</kwd>
          <kwd>Long Island</kwd>
          <kwd>PAH-DNA adducts</kwd>
          <kwd>smoking</kwd>
        </kwd-group>
      </article-meta>
    </front>
    <body>
      <p>
        <s sid="9">Polycyclic aromatic hydrocarbons (PAHs) are an environmentally ubiquitous class of compounds that are formed during incomplete combustion of organic substances.Polycyclic aromatic hydrocarbons (PAHs) are an environmentally ubiquitous class of compounds that are formed during incomplete combustion of organic substances.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
        <s sid="10">Several PAHs have been classified as probable human carcinogens (<xref ref-type="bibr" rid="b5-ehp-117-552">Boffetta et al. 1997</xref>; <xref ref-type="bibr" rid="b53-ehp-117-552">Shimada 2006</xref>).Several PAHs have been classified as probable human carcinogens (<xref ref-type="bibr" rid="b5-ehp-117-552">Boffetta et al. 1997</xref>; <xref ref-type="bibr" rid="b53-ehp-117-552">Shimada 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
        <s sid="11">In the general population, the major source of exposure is tobacco smoke (<xref ref-type="bibr" rid="b38-ehp-117-552">Lioy and Greenberg 1990</xref>), with diet (grilled/smoked foods, cereals, and leafy green vegetables) and exposure to fossil fuel combustion by-products contributing to cumulative exposure (<xref ref-type="bibr" rid="b61-ehp-117-552">Waldman et al. 1991</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
        <s sid="12">Although there is strong evidence for the relationship between PAH exposure and lung, skin, and bladder cancer in humans, it is equivocal as to whether PAH exposure is associated with breast cancer (<xref ref-type="bibr" rid="b5-ehp-117-552">Boffetta et al. 1997</xref>; <xref ref-type="bibr" rid="b19-ehp-117-552">Gammon and Santella 2008</xref>; <xref ref-type="bibr" rid="b53-ehp-117-552">Shimada 2006</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="13">PAH&#8211;DNA adducts reflect not only PAH exposure but also the body&#8217;s ability to metabolize these compounds.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
        <s sid="14">The formation of these carcinogen&#8211;DNA adducts is recognized as a key event in the initiation of carcinogenesis (<xref ref-type="bibr" rid="b18-ehp-117-552">Gammon et al. 2004b</xref>; <xref ref-type="bibr" rid="b29-ehp-117-552">Hecht 2003</xref>; <xref ref-type="bibr" rid="b64-ehp-117-552">Wogan et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
        <s sid="15">In the Long Island Breast Cancer Study Project (LIBCSP), a large population-based case&#8211;control study, blood levels of PAH&#8211;DNA adducts were associated with a modest 29&#8211;35% elevation in breast cancer risk among women (<xref ref-type="bibr" rid="b18-ehp-117-552">Gammon et al 2004b</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="16">These findings are consistent with previously conducted, smaller hospital-based studies (<xref ref-type="bibr" rid="b37-ehp-117-552">Li et al. 1996</xref>, <xref ref-type="bibr" rid="b36-ehp-117-552">2002</xref>; <xref ref-type="bibr" rid="b48-ehp-117-552">Rundle et al. 2000a</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
        <s sid="17">Animal studies have provided further support for the role of PAHs as mammary carcinogens (<xref ref-type="bibr" rid="b8-ehp-117-552">Cavalieri et al. 1991</xref>; <xref ref-type="bibr" rid="b13-ehp-117-552">el-Bayoumy et al. 1995</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
        <s sid="18">Although a significant association between breast cancer risk and detectable PAH&#8211;DNA adducts has been noted, a dose&#8211;response relationship was not observed in the LIBCSP.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="19">Further stratification by known sources of PAH exposure, such as cigarette smoking or the consumption of PAH-containing foods, did not modify this association (<xref ref-type="bibr" rid="b18-ehp-117-552">Gammon et al. 2004b</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="20">These findings are consistent with those from smaller studies (<xref ref-type="bibr" rid="b33-ehp-117-552">Hu et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
        <s sid="21">The lack of a dose response effect suggests that there may be subgroups of women who are more genetically susceptible to the carcinogenic effects of PAH exposure on breast tissue.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="22">Inherited differences in the metabolism of PAHs, interindividual differences in enzyme expression, and induction may be key determinants in individual breast cancer susceptibility (<xref ref-type="bibr" rid="b53-ehp-117-552">Shimada 2006</xref>).<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp3" novelty="None" advantage="None"/></s>
        <s sid="23">Genetic differences in metabolic activation and detoxification of PAHs have been shown to affect differences in phenotypic biomarkers such as urinary metabolites and are hypothesized to influence cancer risk (<xref ref-type="bibr" rid="b6-ehp-117-552">Brescia et al. 2004</xref>; <xref ref-type="bibr" rid="b24-ehp-117-552">Hatsukami et al. 2006</xref>; <xref ref-type="bibr" rid="b30-ehp-117-552">Hecht et al. 2006</xref>; <xref ref-type="bibr" rid="b35-ehp-117-552">Kuljukka-Rabb et al. 2002</xref>; <xref ref-type="bibr" rid="b58-ehp-117-552">Upadhyaya et al. 2006</xref>; <xref ref-type="bibr" rid="b64-ehp-117-552">Wogan et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/></s>
        <s sid="24">Further investigation of these genetic differences in the deactivation of PAH metabolites may contribute to our understanding of the lack of a dose&#8211;response relationship and increased understanding of breast cancer risk.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="25">The phase II metabolic super family of GST enzymes is involved in the metabolic activation and deactivation of PAH metabolites, and polymorphisms in these genes lead to specific changes in enzyme function and the capacity to metabolize PAH compounds (<xref ref-type="bibr" rid="b27-ehp-117-552">Hecht 1999</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/></s>
        <s sid="26">The <italic>GSTM1</italic> null polymorphism [GenBank BC036805; <xref ref-type="bibr" rid="b42-ehp-117-552">National Center for Biotechnology Information (NCBI) 2009a</xref>] results in the absence of isoenzyme (mu) expression and reduced glutathione binding efficiency of PAH epoxides and other genotoxic substrates (<xref ref-type="bibr" rid="b25-ehp-117-552">Hayes and Pulford 1995</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/></s>
        <s sid="27">The <italic>GSTP</italic> 1le105Val polymorphism [<italic>GSTP1</italic>; Unigene Hs.523836 (<xref ref-type="bibr" rid="b43-ehp-117-552">NCBI 2009b</xref>)] is associated with reduced isoenzyme (pi) expression and a reduced capacity to inactivate carcinogens, including the diol epoxides created during phase I metabolism of PAHs (<xref ref-type="bibr" rid="b10-ehp-117-552">Coles and Kadlubar 2003</xref>; <xref ref-type="bibr" rid="b44-ehp-117-552">Pavanello and Clonfero 2000</xref>; <xref ref-type="bibr" rid="b51-ehp-117-552">Ryberg et al. 1997</xref>; <xref ref-type="bibr" rid="b62-ehp-117-552">Watson et al. 1998</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/></s>
        <s sid="28">The <italic>GSTT1</italic> null polymorphism (Genbank X79389) results in the absence of (theta) isoenzyme (<xref ref-type="bibr" rid="b25-ehp-117-552">Hayes and Pulford 1995</xref>), but the role of this polymorphism in relation to PAH metabolism is uncertain (<xref ref-type="bibr" rid="b44-ehp-117-552">Pavanello and Clonfero 2000</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot4" novelty="None" advantage="None"/></s>
        <s sid="29">On the one hand, the theta isoenzyme is thought to activate alkylating agents, such as nitrosamines present in tobacco smoke (<xref ref-type="bibr" rid="b27-ehp-117-552">Hecht 1999</xref>; <xref ref-type="bibr" rid="b44-ehp-117-552">Pavanello and Clonfero 2000</xref>); on the other hand, in human erythrocytes, the theta isoenzyme binds reactive conjugates to glutathione, inhibiting genotoxic damage to DNA (<xref ref-type="bibr" rid="b45-ehp-117-552">Pelin et al. 1996</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/></s>
        <s sid="30">GSTs conjugate PAH diol epoxides into water-soluble products, and GST enzymes also protect against products of oxidative stress (<xref ref-type="bibr" rid="b40-ehp-117-552">Mitrunen and Hirvonen 2003</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/></s>
        <s sid="31"><italic>GSTA1</italic> (Unigene Hs.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/></s>
        <s sid="32">446309) is thought to decrease reactive oxygen species and, via an increase in antioxidant levels, to also play an active role in PAH metabolism (<xref ref-type="bibr" rid="b1-ehp-117-552">Ahn et al. 2006</xref>; <xref ref-type="bibr" rid="b11-ehp-117-552">Coles et al. 2005</xref>; <xref ref-type="bibr" rid="b34-ehp-117-552">Korashy and El-Kadi 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/></s>
        <s sid="33">For <italic>GSTA1</italic>, two alleles, <italic>hGSTA1*A</italic> and <italic>hGSTA1*B</italic>, differ in three linked base changes in the 5&#8242; promoter region of the gene: T&#8594;G at nucleotide 567, C&#8594;T at nucleotide 69, and G&#8594;A at nucleotide 52 (<xref ref-type="bibr" rid="b12-ehp-117-552">Coles et al 2001a</xref>, <xref ref-type="bibr" rid="b9-ehp-117-552">2001b</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/></s>
        <s sid="34">These substitutions result in differential expression (<xref ref-type="bibr" rid="b9-ehp-117-552">Coles et al. 2001b</xref>), with lower transcriptional activation with <italic>GSTA1*B</italic> (variant) than with <italic>GSTA1*A</italic> (common) alleles.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/></s>
        <s sid="35">It has been demonstrated by our group that the variant <italic>GSTA1*B</italic>/<italic>B</italic> genotype is associated with higher risk of breast cancer among smokers compared with nonsmokers with the <italic>A</italic>/<italic>A*</italic> genotype (<xref ref-type="bibr" rid="b1-ehp-117-552">Ahn et al. 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="36">Only one breast cancer study (<xref ref-type="bibr" rid="b50-ehp-117-552">Rundle et al. 2000b</xref>) has reported on a potential interaction between <italic>GSTM1</italic> null genotype and PAH&#8211;DNA adducts.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac23" novelty="None" advantage="None"/></s>
        <s sid="37">However, the sample size was small (&lt; 100 cases), yielding unstable effect estimates and prohibiting exploration of more than one single nucleotide polymorphism from among the many that contribute to this complex cascade of activation and detoxification.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot5" novelty="None" advantage="None"/></s>
        <s sid="38">Investigating whether genetically determined differences in multiple <italic>GST</italic> genotypes modify the association between breast cancer risk and PAH exposure may improve our ability to identify women who are susceptible to the carcinogenic effects of PAHs on breast tissue.Investigating whether genetically determined differences in multiple <italic>GST</italic> genotypes modify the association between breast cancer risk and PAH exposure may improve our ability to identify women who are susceptible to the carcinogenic effects of PAHs on breast tissue.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="39">The goal of our present analysis was to investigate whether multiple <italic>GST</italic> polymorphisms modified the relationship between PAH exposure and breast cancer, using the lymphocyte PAH&#8211;DNA adduct biomarker as our primary exposure measure of interest using a large, population-based sample of cases and controls from the LIBCSP.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
        <s sid="40">We also evaluated the interaction between <italic>GST</italic> polymorphisms and smoking status, because smoking behavior was previously identified as the strongest predictor of detectable PAH&#8211;DNA adducts (<xref ref-type="bibr" rid="b52-ehp-117-552">Shantakumar et al. 2005</xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Bac" conceptID="Bac24" novelty="None" advantage="None"/></s>
        <s sid="41">Finally, we investigated the joint effects of smoking status and <italic>GST</italic> polymorphisms on detectable PAH&#8211;DNA adducts among control women.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj5" novelty="None" advantage="None"/></s>
      </p>
      <sec sec-type="methods">
        <title>Methods</title>
        <sec sec-type="methods">
          <title>Study population</title>
          <p>
            <s sid="42">The population-based sample of cases and controls from the LIBCSP has been described previously (<xref ref-type="bibr" rid="b17-ehp-117-552">Gammon et al. 2002a</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
            <s sid="43">Briefly, cases were defined as English-speaking adult women newly diagnosed with breast cancer residing in Nassau County or Suffolk County in Long Island, New York.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
            <s sid="44">Population-based controls were identified through random-digit dialing for women &lt; 65 years of age, and by Health Care Finance rosters for women &#8805; 65 years of age within the same counties, and frequency matched them (by 5-year age groups) to cases.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
            <s sid="45">Participants were between 20 and 98 years of age; 94% were white, 4% were black, and 2% other races/ethnicities.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
            <s sid="46">The study protocol was approved by the institutional review boards of the collaborating institutions, and written informed consent was obtained from the LIBCSP participants.<CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Data collection</title>
          <p>
            <s sid="47">Respondents to the case&#8211;control interview included 1,508 cases and 1,556 controls (<xref ref-type="bibr" rid="b17-ehp-117-552">Gammon et al. 2002a</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
            <s sid="48">The 2-hr in-person structured interview collected data on history of cigarette smoking (current, past), exposure to environmental tobacco smoke in the residential home throughout the life course (<xref ref-type="bibr" rid="b16-ehp-117-552">Gammon et al. 2004a</xref>), and other characteristics potentially relevant to breast cancer risk.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
            <s sid="49">Blood samples were obtained from 73% of cases and 73% of controls (<xref ref-type="bibr" rid="b18-ehp-117-552">Gammon et al. 2004b</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Laboratory assays</title>
          <p>
            <s sid="50">We processed the blood samples collected by <xref ref-type="bibr" rid="b18-ehp-117-552">Gammon et al. (2004b)</xref>, isolated the DNA and completed genotyping for <italic>GSTT1</italic> and <italic>GSTM1</italic> as previously described (<xref ref-type="bibr" rid="b56-ehp-117-552">Steck et al. 2007b</xref>), by a multiplex polymerase chain reaction method as previously described (<xref ref-type="bibr" rid="b4-ehp-117-552">Bell et al. 1992</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/></s>
            <s sid="51">Genotyping for <italic>GSTP1</italic> (Ile105Val; rs1695) (<xref ref-type="bibr" rid="b56-ehp-117-552">Steck et al. 2007b</xref>) and <italic>GSTA1</italic> (<xref ref-type="bibr" rid="b1-ehp-117-552">Ahn et al. 2006</xref>) was completed as previously described by matrix-assisted laser desorption/ionization time-of-flight assay (<xref ref-type="bibr" rid="b14-ehp-117-552">Fannon 2002</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
            <s sid="52">We included positive and negative controls in each batch, and a random 10% repeated sampling yielded a 97% concordance.<CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="None" advantage="None"/></s>
            <s sid="53">Genotype distributions of <italic>GSTA1</italic> (<italic>p</italic> = 0.81) and <italic>GSTP1</italic> (<italic>p</italic> = 0.38) were in Hardy-Weinberg equilibrium among controls.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
            <s sid="54">The number of cases and controls, respectively, for whom genotyping was successful varied with genotype (<italic>n</italic> = 1,041 and 1,090 for <italic>GSTA1</italic>, 983 and 1,016 for <italic>GSTT1</italic>, 975 and 1,001 for <italic>GSTM1</italic>, and 1,027 and 1,069 for <italic>GSTP1</italic>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/></s>
            <s sid="55">Missing genotype data were primarily due to insufficient DNA (<xref ref-type="bibr" rid="b1-ehp-117-552">Ahn et al. 2006</xref>; <xref ref-type="bibr" rid="b56-ehp-117-552">Steck et al. 2007b</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="56">PAH&#8211;DNA adducts were measured in peripheral mononuclear cell DNA using competitive enzyme-linked immunosorbent assay as previously described (<xref ref-type="bibr" rid="b20-ehp-117-552">Gammon et al. 2002b</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="None" advantage="None"/></s>
            <s sid="57">PAH&#8211;DNA adduct measurements were available for 873 cases and 941 controls who donated sufficient blood volume for the assay, as described previously (<xref ref-type="bibr" rid="b18-ehp-117-552">Gammon et al. 2004b</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met9" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Statistical methods</title>
          <p>
            <s sid="58">We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression using SAS version 9.0 (SAS Institute Inc., Cary, NC).<CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="None" advantage="None"/></s>
            <s sid="59">All models were adjusted for age at reference (date of diagnosis for cases and date of identification for controls), the frequency-matching factor.<CoreSc1 atype="GSC" type="Met" conceptID="Met11" novelty="None" advantage="None"/></s>
            <s sid="60">Covariates considered as potential confounders included race, family history of breast cancer, parity, age at menarche, age at first pregnancy, menopausal status, lifetime alcohol intake, education, and smoking status.<CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="None" advantage="None"/></s>
            <s sid="61">We considered a covariate a confounder and included it in the models if it changed the ORs by more than 10% (<xref ref-type="bibr" rid="b32-ehp-117-552">Hosmer and Lemeshow 1989</xref>); however, adjustment by these potential confounders did not appreciably change the ORs, and therefore only the age-adjusted estimates are shown.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj6" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="62">For our first set of analyses, our goal was to determine whether breast cancer risk is associated with the <italic>GST</italic> polymorphisms and whether they interact with PAH exposures, either alone or jointly, to affect breast cancer risk.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/></s>
            <s sid="63">We previously reported that the ORs for the association between breast cancer and individual <italic>GST</italic> genotypes were not substantially elevated (<xref ref-type="bibr" rid="b1-ehp-117-552">Ahn et al. 2006</xref>; <xref ref-type="bibr" rid="b56-ehp-117-552">Steck et al. 2007b</xref>), although risk was elevated when we considered multiple <italic>GST</italic>s (<xref ref-type="bibr" rid="b1-ehp-117-552">Ahn et al. 2006</xref>; <xref ref-type="bibr" rid="b56-ehp-117-552">Steck et al 2007b</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac25" novelty="None" advantage="None"/></s>
            <s sid="64">Here, we focus primarily on the analyses that examine the interaction of <italic>GST</italic>s with adducts and smoking, using the following methods.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj7" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="65">We estimated the ORs for breast cancer in relation to potential interactions between various PAH measures and the <italic>GST</italic> polymorphisms, <italic>a</italic>) considering each polymorphism separately (<xref ref-type="table" rid="t1-ehp-117-552">Table 1</xref>), and (<italic>b</italic>) by grouping individuals based on the number of variant alleles for any of the four <italic>GST</italic> polymorphisms considered (<xref ref-type="table" rid="t2-ehp-117-552">Tables 2</xref> and <xref ref-type="table" rid="t3-ehp-117-552">3</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met13" novelty="None" advantage="None"/></s>
            <s sid="66">For this group of analyses, the reference group included women with <italic>GSTT1</italic> present, <italic>GSTM1</italic> present, <italic>GSTP1</italic> common (<italic>AG</italic> or <italic>GG</italic>), or <italic>GSTA1</italic> common (<italic>A</italic>/<italic>A*</italic>) genotypes.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
            <s sid="67">Using this approach, we explored the effect of even a single at-risk genotype, among those who carried common alleles for the other <italic>GST</italic>s considered.<CoreSc1 atype="GSC" type="Met" conceptID="Met14" novelty="None" advantage="None"/></s>
            <s sid="68">We chose to group the genes this way based on experimental evidence indicating reduced or no enzyme activity for the variant and null genotypes.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
            <s sid="69">In terms of metabolism, the <italic>GSTP1</italic> valine genotype is thought to be associated with lower glutathione <italic>S</italic>-transferase pi enzyme activity compared with the <italic>GSTP1</italic> isoleucine genotype, which plays a key role in the detoxification of benzo[<italic>a</italic>]pyrene diol epoxide, a major carcinogen present in tobacco smoke (<xref ref-type="bibr" rid="b15-ehp-117-552">Fields et al. 1998</xref>; <xref ref-type="bibr" rid="b27-ehp-117-552">Hecht 1999</xref>; <xref ref-type="bibr" rid="b41-ehp-117-552">Nakajima et al. 1995</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac26" novelty="None" advantage="None"/></s>
            <s sid="70">To explore these potential gene&#8211;PAH interactions, we developed separate models for women based on the presence or absence of the PAH exposure measure [PAH&#8211;DNA adducts (detectable/not detectable); self-reported cigarette smoking status (ever/never, or current/past/never)] or pack years of smoking history (&lt; 15 years, 15&#8211;30 years, &gt; 30 years).<CoreSc1 atype="GSC" type="Goa" conceptID="Goa3" novelty="None" advantage="None"/></s>
            <s sid="71">We also developed models for all women that included multiplicative interaction terms (<xref ref-type="bibr" rid="b32-ehp-117-552">Hosmer and Lemeshow 1989</xref>); gene&#8211;environment interactions were formally assessed by examining departures from multiplicity by comparing models with and without the interaction term using the likelihood ratio test (LRT) (<xref ref-type="bibr" rid="b32-ehp-117-552">Hosmer and Lemeshow 1989</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met15" novelty="None" advantage="None"/></s>
            <s sid="72">In addition, we investigated potential interactions on the additive scale (<xref ref-type="bibr" rid="b32-ehp-117-552">Hosmer and Lemeshow 1989</xref>) using joint indicator terms for genotype only, for PAH measure only, and for both genotype and PAH measure (<xref ref-type="table" rid="t3-ehp-117-552">Tables 3</xref> and <xref ref-type="table" rid="t4-ehp-117-552">4</xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj8" novelty="None" advantage="None"/></s>
            <s sid="73">Interaction contrast ratios (ICRs) and their 95% CIs were calculated to measure the relative excess risk due to interaction (<xref ref-type="bibr" rid="b3-ehp-117-552">Assmann et al. 1996</xref>; <xref ref-type="bibr" rid="b46-ehp-117-552">Rothman and Greenland 1998</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met16" novelty="None" advantage="None"/></s>
            <s sid="74">We also considered other categorizations of smoking exposure status that incorporated information collected by the questionnaire on environmental tobacco smoke (<xref ref-type="bibr" rid="b16-ehp-117-552">Gammon et al. 2004a</xref>), but the cell sizes were too small to yield meaningful results, so we do not show these data.<CoreSc1 atype="GSC" type="Met" conceptID="Met17" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="75">For our second set of analyses, our goal was to determine the association between PAH&#8211;DNA adducts and the <italic>GST</italic> variant alleles among control women only.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa4" novelty="None" advantage="None"/></s>
            <s sid="76">We used unconditional logistic regression with detectable adducts as the dependent variable, and <italic>GST</italic>s as the independent variable, controlling for age at reference and season of blood draw (<xref ref-type="table" rid="t4-ehp-117-552">Table 4</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met18" novelty="None" advantage="None"/></s>
            <s sid="77">We also investigated the main effect of each genotype or number of variant alleles on the outcome of detectable PAH&#8211;DNA adducts in a multivariate model adjusted for age, smoking status, and season of blood draw.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj9" novelty="None" advantage="None"/></s>
            <s sid="78">In a previous study (<xref ref-type="bibr" rid="b52-ehp-117-552">Shantakumar et al. 2005</xref>), we found that cigarette smoking was a significant predictor of detectable PAH&#8211;DNA adducts among this population-based sample; thus, we also explored whether the <italic>GST</italic> genotypes modified the association between smoking status and detectable adducts.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj10" novelty="None" advantage="None"/></s>
            <s sid="79">We also considered potential interactions with cigarette smoke because of its link to our biomarker, although we recognize that other PAH sources and other constituents of tobacco smoke could potentially interact with <italic>GST</italic> polymorphisms to affect risk; however, these other constituents of tobacco smoke have not been linked to breast cancer risk in a human study.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot6" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="display-objects">
        <title>Tables</title>
        <table-wrap id="t1-ehp-117-552" position="float">
          <label>Table 1</label>
          <caption>
            <p>Age-adjusted ORs (95% CIs) for the individual <italic>GST</italic> genotypes on the associations between smoking status and breast cancer risk.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800119.t001" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t2-ehp-117-552" position="float">
          <label>Table 2</label>
          <caption>
            <p>Age-adjusted ORs (95% CIs) for the individual <italic>GST</italic> genotypes on the associations between PAH&#8211;DNA adducts and breast cancer risk.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800119.t002" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t3-ehp-117-552" position="float">
          <label>Table 3</label>
          <caption>
            <p>Age-adjusted ORs (95% CIs) for the effects of number of variant genotypes, PAH&#8211;DNA adducts, and risk of breast cancer.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800119.t003" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t4-ehp-117-552" position="float">
          <label>Table 4</label>
          <caption>
            <p>Age-adjusted ORs (95% CIs) for the effect of number of variant genotypes, smoking status, and risk of breast cancer.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800119.t004" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t5-ehp-117-552" position="float">
          <label>Table 5</label>
          <caption>
            <p>Age-adjusted ORs (95% CIs) for the joint effect of <italic>GST</italic> polymorphisms and smoking on the outcome of detectable PAH&#8211;DNA adducts among control women.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800119.t005" xlink:type="simple"/>
        </table-wrap>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <sec>
          <title>Individual GSTs, PAHs, and breast cancer risk</title>
          <p>
            <s sid="80">As shown in <xref ref-type="table" rid="t1-ehp-117-552">Tables 1</xref> and <xref ref-type="table" rid="t2-ehp-117-552">2</xref>, we did not observe substantial effect modification, on a multiplicative or additive scale, by any of the individual genotypes on the associations between breast cancer risk and PAH exposure (PAH&#8211;DNA adducts or cigarette smoking).<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Multiple GSTs and breast cancer risk</title>
          <p>
            <s sid="81">The ORs for the association between breast cancer risk and multiple <italic>GST</italic> variant alleles were 1.10 (95% CI, 0.77&#8211;1.57) for three or more variants, 0.76 (95% CI, 0.56&#8211;1.03) for two variants, and 0.80 (95% CI, 0.59&#8211;1.08) for one variant.<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/></s>
            <s sid="82">When we considered the combined effects of <italic>GSTM1</italic>, <italic>-P1</italic>, <italic>-T1</italic>, and -<italic>A1</italic> variants that are coded based on their PAH-related biologic activity (rather than for their isothiocyanate-related activity), we did not find a significant association between the number of variant <italic>GST</italic> alleles and breast cancer risk.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Multiple GSTs, PAHs, and breast cancer risk</title>
          <p>
            <s sid="83"><xref ref-type="table" rid="t3-ehp-117-552">Table 3</xref> illustrates the potential joint effects of PAH&#8211;DNA adducts and the number of <italic>GST</italic> polymorphisms (one, two, or three or more variants) and breast cancer risk.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/></s>
            <s sid="84">We observed a 56% increase in risk (OR = 1.56; 95% CI, 1.13&#8211;2.16) among women with detectable adducts and three or more <italic>GST</italic> variants [<italic>GSTT1</italic> null variant, <italic>GSTM1</italic> null variant, <italic>GSTP1 AG</italic>/<italic>GG</italic> genotype, <italic>GSTA1</italic> common (<italic>A*</italic>/<italic>B*</italic> or <italic>B*</italic>/<italic>B*</italic>) genotypes] compared with those with all common genotypes and no detectable PAH&#8211;DNA adducts.<CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/></s>
            <s sid="85">The corresponding OR for three or more variants and no detectable adducts was 0.93 (95% CI, 0.56&#8211;1.56).<CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/></s>
            <s sid="86">Women with one variant allele and no detectable adducts had a 44% reduced risk of breast cancer compared with women with all common alleles and no detectable adducts (OR, 0.56; 95% CI, 0.40&#8211;0.77); the corresponding OR for detectable adducts was not significant (OR, 0.97; 95% CI, 0.78&#8211;1.20; <xref ref-type="table" rid="t3-ehp-117-552">Table 3</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="87">As shown in <xref ref-type="table" rid="t4-ehp-117-552">Table 4</xref>, the ORs for the association between breast cancer risk and the number of <italic>GST</italic> variant alleles varied little with smoking status, and results for interaction on either a multiplicative or additive scale were not statistically significant.<CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/></s>
            <s sid="88">For example, the OR associated with three or more <italic>GST</italic> variants was 1.18 among ever smokers (95% CI, 0.82&#8211;1.69) but was 1.44 among never smokers (95% CI, 0.97&#8211;2.14).<CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/></s>
            <s sid="89">Results for the interaction between multiple <italic>GST</italic> variants and pack-years of smoking (data not shown) are similar to those shown in <xref ref-type="table" rid="t4-ehp-117-552">Table 4</xref>.<CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="90">When we categorized ever smokers by whether they were current or past smokers, the OR for the association between breast cancer risk and three or more <italic>GST</italic> variants was 0.62 (95% CI, 0.27&#8211;1.43) among current smokers, and 1.66 (95% CI, 0.93&#8211;2.97) among past smokers, compared with never smokers with all four common alleles.<CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/></s>
            <s sid="91">However, the category sizes upon which these estimates are based were small (data not shown), and the <italic>p</italic>-value for the interaction on a multiplicative scale was 0.31.<CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>GSTs, smoking, and PAH&#8211;DNA adducts among control women</title>
          <p>
            <s sid="92">We did not observe a significant association between any single <italic>GSTT1</italic>, <italic>GSTM1</italic>, <italic>GSTP1</italic>, or <italic>GSTA1</italic> polymorphism and detectable PAH&#8211;DNA adducts among the control women (<italic>GSTT1</italic>: OR, 1.09; 95% CI, 0.77&#8211;1.56; <italic>GSTM1</italic>: OR, 0.93; 95% CI, 0.69&#8211;1.25; <italic>GSTP1</italic>: OR, 0.95; 95% CI, 0.72&#8211;1.27; <italic>GSTA1</italic>: OR, 1.15; 95% CI, 0.86&#8211;1.53) or the number of variant genotypes and detectable PAH&#8211;DNA adducts (one variant compared with all common alleles: OR, 1.60; 95% CI, 0.92&#8211;2.79; two variants compared with all common alleles: OR, 1.35; 95% CI, 0.77&#8211;2.36; three or more variants compared with all common alleles: OR, 1.45; 95% CI, 0.75&#8211;2.82).<CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/></s>
            <s sid="93"><xref ref-type="table" rid="t5-ehp-117-552">Table 5</xref> shows the association between <italic>GST</italic> polymorphisms and PAH&#8211;DNA adducts among control women stratified by smoking status.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/></s>
            <s sid="94">Women who ever smoked and had the <italic>GSTM1</italic> present genotype had a 35% reduced odds (OR, 0.65; 95% CI, 0.45&#8211;0.93) of having detectable PAH&#8211;DNA adducts compared with never smokers with the same genotype.<CoreSc1 atype="GSC" type="Res" conceptID="Res14" novelty="None" advantage="None"/></s>
            <s sid="95">We noted similar results forever smokers with the <italic>GSTM1</italic> null genotype compared with never smokers with the <italic>GSTM1</italic> common genotype (OR, 0.64; 95% CI, 0.43&#8211;0.93).<CoreSc1 atype="GSC" type="Res" conceptID="Res15" novelty="None" advantage="None"/></s>
            <s sid="96">Ever smokers with the <italic>GSTT1</italic> present genotype had a 27% reduced odds of PAH&#8211;DNA adducts (OR, 0.73; 95% CI, 0.53&#8211;0.99) compared with never smokers with the same genotype.<CoreSc1 atype="GSC" type="Res" conceptID="Res16" novelty="None" advantage="None"/></s>
            <s sid="97">Ever smokers with the common <italic>GSTA1</italic> genotype had a reduced odds of PAH&#8211;DNA adducts compared with never smokers with the same genotype (OR, 0.67; 95% CI, 0.47&#8211;0.96; <xref ref-type="table" rid="t5-ehp-117-552">Table 5</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res17" novelty="None" advantage="None"/></s>
            <s sid="98">We found no evidence of effect modification between any of the individual genotypes and smoking status on PAH&#8211;DNA adduct status on the multiplicative scale (LRT <italic>p</italic>-values: <italic>GSTT1</italic>, 0.20; <italic>GSTM1</italic>, 0.75; <italic>GSTP1</italic>, 0.15; <italic>GSTA1</italic>, 0.40) or on the additive scale.<CoreSc1 atype="GSC" type="Res" conceptID="Res18" novelty="None" advantage="None"/></s>
            <s sid="99">We did not find statistical evidence between number of variant alleles and smoking status on the odds of developing detectable PAH&#8211;DNA adducts on the additive scale (one-variant allele: ICR, 0.28; 95% CI, &#8211;0.39 to 0.45; two-variant alleles: ICR, &#8211;0.091; 95% CI, &#8211;0.57 to 0.38; three or more variant alleles: ICR, 0.177; 95% CI, &#8211;0.23 to 0.59) or on the multiplicative scale (<italic>p</italic>-value from the LRT = 0.13).<CoreSc1 atype="GSC" type="Res" conceptID="Res19" novelty="None" advantage="None"/></s>
            <s sid="100">When considering the number of adducts as a continuous outcome (data not shown), we found no evidence of a main effect of the individual genotypes on the number of adducts in an age-adjusted model (<italic>GSTT1 p</italic> = 0.86, <italic>GSTM1 p</italic> = 0.54, <italic>GSTP1 p</italic> = 0.91, <italic>GSTA1 p</italic> = 0.86).<CoreSc1 atype="GSC" type="Res" conceptID="Res20" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>
          <s sid="101">To the best of our knowledge, this is the first epidemiologic investigation of breast cancer to consider the joint effects of four <italic>GST</italic> polymorphisms and several measures of PAH exposure, including a PAH&#8211;DNA adduct biomarker.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj11" novelty="None" advantage="None"/></s>
          <s sid="102">Despite the biologic plausibility of our hypothesis, we found no strong evidence for an interaction between the number of variant <italic>GST</italic> alleles with various measures of PAH exposure (including ever/never smoking status, pack-years of smoking, or detected PAH&#8211;DNA adducts) and breast cancer risk, nor did we find an association among the control women between number of variant <italic>GST</italic> polymorphisms and the outcome of detectable PAH&#8211;DNA adducts.<CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
          <s sid="103">We found some evidence for a reduced risk of detectable adducts among control women who were ever smokers regardless of whether they had the <italic>GSTM1</italic> deletion polymorphism or the present genotype (<xref ref-type="table" rid="t5-ehp-117-552">Table 5</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res21" novelty="None" advantage="None"/></s>
          <s sid="104">We also report for the first time that among controls with the <italic>A*</italic>/<italic>A* GSTA1</italic> genotype, ever smokers had lower odds of having detectable PAH&#8211;DNA adducts than did never smokers with the same genotype (OR, 0.62; 95% CI, 0.41&#8211;0.92).<CoreSc1 atype="GSC" type="Res" conceptID="Res22" novelty="None" advantage="None"/></s>
        </p>
        <sec>
          <title>GST polymorphisms and breast cancer risk</title>
          <p>
            <s sid="105">A few previous studies (<xref ref-type="bibr" rid="b31-ehp-117-552">Helzlsouer et al. 1998</xref>; <xref ref-type="bibr" rid="b59-ehp-117-552">van der Hel et al. 2005</xref>) including our own have found that individual polymorphisms in <italic>GSTA1</italic> (<xref ref-type="bibr" rid="b1-ehp-117-552">Ahn et al. 2006</xref>), <italic>GSTM1</italic> null (<xref ref-type="bibr" rid="b31-ehp-117-552">Helzlsouer et al. 1998</xref>; <xref ref-type="bibr" rid="b54-ehp-117-552">Spurdle et al. 2007</xref>), and <italic>GSTT1</italic> null (<xref ref-type="bibr" rid="b59-ehp-117-552">van der Hel et al. 2005</xref>) and <italic>GSTP1</italic> (heterozygote or homozygote valine) (<xref ref-type="bibr" rid="b31-ehp-117-552">Helzlsouer et al. 1998</xref>) are modestly associated with breast cancer, although others have reported no association with <italic>GSTT1</italic> (<xref ref-type="bibr" rid="b21-ehp-117-552">Garc&#237;a-Closas et al. 1999</xref>; <xref ref-type="bibr" rid="b31-ehp-117-552">Helzlsouer et al, 1998</xref>; <xref ref-type="bibr" rid="b60-ehp-117-552">Vogl et al. 2004</xref>), <italic>GSTP1</italic> (<xref ref-type="bibr" rid="b60-ehp-117-552">Vogl et al. 2004</xref>), or <italic>GSTM1</italic> (<xref ref-type="bibr" rid="b2-ehp-117-552">Ambrosone et al. 1995</xref>; <xref ref-type="bibr" rid="b21-ehp-117-552">Garc&#237;a-Closas et al. 1999</xref>; <xref ref-type="bibr" rid="b60-ehp-117-552">Vogl et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac27" novelty="None" advantage="None"/></s>
            <s sid="106">Effects of multiple combinations of <italic>GST</italic> polymorphisms on breast cancer risk have previously been conducted in smaller studies, with conflicting findings (<xref ref-type="bibr" rid="b31-ehp-117-552">Helzlsouer et al. 1998</xref>; <xref ref-type="bibr" rid="b56-ehp-117-552">Steck et al. 2007b</xref>; <xref ref-type="bibr" rid="b59-ehp-117-552">van der Hel et al. 2005</xref>; <xref ref-type="bibr" rid="b60-ehp-117-552">Vogl et al. 2004</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot7" novelty="None" advantage="None"/></s>
            <s sid="107">Combined effect of all three <italic>GSTT1</italic>, <italic>GSTM1</italic>, and <italic>GSTP1</italic> variants have been reported to have greater than a 3-fold increase in breast cancer risk compared with women with the common genotype for all three polymorphisms (<xref ref-type="bibr" rid="b31-ehp-117-552">Helzlsouer et al. 1998</xref>; <xref ref-type="bibr" rid="b56-ehp-117-552">Steck et al. 2007b</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac28" novelty="None" advantage="None"/></s>
            <s sid="108">In this analysis, in which we considered the combined effects of the <italic>GSTT1</italic>, <italic>-M1</italic>, <italic>-P1</italic>, and -<italic>A1</italic> variants that are coded based on their PAH-related biologic activity (rather than for their isothiocyanate-related activity), we did not find a significant association between the number of variant <italic>GST</italic> alleles and breast cancer risk.<CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>GST polymorphisms, PAHs, and breast cancer</title>
          <p>
            <s sid="109">Previous studies have differed on whether <italic>GST</italic> polymorphisms modify the association between cigarette smoking and breast cancer risk (<xref ref-type="bibr" rid="b39-ehp-117-552">Millikan et al. 2000</xref>; <xref ref-type="bibr" rid="b57-ehp-117-552">Terry and Goodman 2006</xref>; <xref ref-type="bibr" rid="b59-ehp-117-552">van der Hel et al. 2005</xref>; <xref ref-type="bibr" rid="b60-ehp-117-552">Vogl et al. 2004</xref>; <xref ref-type="bibr" rid="b65-ehp-117-552">Zheng et al. 2002</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot8" novelty="None" advantage="None"/></s>
            <s sid="110">Smaller studies have reported that smoking did not modify associations between <italic>GSTT1</italic> (<xref ref-type="bibr" rid="b60-ehp-117-552">Vogl et al. 2004</xref>), <italic>GSTM1</italic> (<xref ref-type="bibr" rid="b59-ehp-117-552">van der Hel et al. 2005</xref>; <xref ref-type="bibr" rid="b60-ehp-117-552">Vogl et al. 2004</xref>), or <italic>GSTP1</italic> polymorphisms (<xref ref-type="bibr" rid="b60-ehp-117-552">Vogl et al. 2004</xref>) and breast cancer, whereas former smokers with <italic>GSTT1</italic> null were found to have an increased risk of breast cancer compared with never smokers with <italic>GSTT1</italic> present (<xref ref-type="bibr" rid="b59-ehp-117-552">van der Hel et al. 2005</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot9" novelty="None" advantage="None"/></s>
            <s sid="111">For example, one recent breast cancer meta-analysis reported no interaction between individual <italic>GST</italic> polymorphisms and smoking, whereas another meta-analysis reported positive associations between breast cancer risk and <italic>GSTT1</italic> present and <italic>GSTM1</italic> null genotypes among smokers (<xref ref-type="bibr" rid="b57-ehp-117-552">Terry and Goodman 2006</xref>; <xref ref-type="bibr" rid="b60-ehp-117-552">Vogl et al. 2004</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot10" novelty="None" advantage="None"/></s>
            <s sid="112">In contrast, we observed an increased risk of breast cancer with three or more variant <italic>GST</italic> alleles in a previous analysis (<xref ref-type="bibr" rid="b56-ehp-117-552">Steck et al. 2007b</xref>), but no increased risk with number of variant alleles as defined by low PAH-metabolizing activity, and no evidence of gene&#8211;environment interaction with PAH exposure.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac29" novelty="None" advantage="None"/></s>
            <s sid="113">Our present findings are unique in that we investigated four <italic>GST</italic> polymorphisms simultaneously in a single large study.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj12" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="114">To the best of our knowledge, this is the first study to examine the interaction between PAH&#8211;DNA adducts and individual/combined effects of <italic>GSTA1</italic>, <italic>GSTM1</italic>, <italic>GSTP1</italic>, and <italic>GSTT1</italic> genotypes on breast cancer risk.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj13" novelty="None" advantage="None"/></s>
            <s sid="115">We found no pronounced adverse effect for the genotype&#8211;PAH exposure interaction, regardless of the PAH measure.<CoreSc1 atype="GSC" type="Res" conceptID="Res23" novelty="None" advantage="None"/></s>
            <s sid="116">Given that the genetic polymorphisms we examined are known to be functionally associated with deactivation of the active intermediates of PAHs, our findings are not easily interpreted.<CoreSc1 atype="GSC" type="Res" conceptID="Res24" novelty="None" advantage="None"/></s>
            <s sid="117">It is possible that the PAH&#8211;DNA adduct biomarker effect estimates already reflect any effects associated with metabolic variation; however, if this were true, then any apparent interaction between PAHs and <italic>GST</italic>s should have been evident when examining the joint effects with smoking.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp4" novelty="None" advantage="None"/></s>
            <s sid="118">We found a reduction in risk among women with at least one variant allele and no detectable adducts, but we did not find a similar reduction among these same women in relation to no smoking.<CoreSc1 atype="GSC" type="Res" conceptID="Res25" novelty="None" advantage="None"/></s>
            <s sid="119">Thus, we do not report evidence that PAHs interacted with these polymorphisms to further increase risk.<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="120">We acknowledge that expression of GSTs can be modulated by a variety of factors, including diet.<CoreSc1 atype="GSC" type="Res" conceptID="Res26" novelty="None" advantage="None"/></s>
            <s sid="121">There is extensive literature on animal studies demonstrating an interaction between isothiocyanates and PAHs on cancer risk, and the induction of phase II enzymes by isothiocyanates (<xref ref-type="bibr" rid="b26-ehp-117-552">Hecht 1996</xref>, <xref ref-type="bibr" rid="b28-ehp-117-552">2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac30" novelty="None" advantage="None"/></s>
            <s sid="122">The interaction between GSTs and isothiocyanates does not appear to interact to affect breast cancer risk in humans or the variations in the urinary metabolites of isothiocyanates in our data (<xref ref-type="bibr" rid="b55-ehp-117-552">Steck et al. 2007a</xref>, <xref ref-type="bibr" rid="b56-ehp-117-552">2007b</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac31" novelty="None" advantage="None"/></s>
            <s sid="123">Whether cruciferous vegetable intake would further interact with PAHs and GSTs to affect breast cancer risk is unclear.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot11" novelty="None" advantage="None"/></s>
            <s sid="124">Unfortunately, this study was underpowered to explore such three way interactions despite a large sample size.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot12" novelty="None" advantage="None"/></s>
            <s sid="125">Nevertheless, it may be theoretically possible that breast cancer risk is influenced by a potential three-way interaction of PAH&#8211;DNA adducts, <italic>GST</italic> polymorphisms, and cruciferous vegetable intake, although our current available data do not support this hypothesis (<xref ref-type="bibr" rid="b55-ehp-117-552">Steck et al. 2007a</xref>, <xref ref-type="bibr" rid="b56-ehp-117-552">2007b</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot13" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>GST polymorphisms, smoking, and PAH&#8211;DNA adducts among control women</title>
          <p>
            <s sid="126">We considered the PAH&#8211;DNA adduct outcome as both a continuous and a dichotomous variable (detected/not detected), although the latter may be more informative given the lack of a dose&#8211;response relationship between adducts and breast cancer risk (<xref ref-type="bibr" rid="b20-ehp-117-552">Gammon et al. 2002b</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res27" novelty="None" advantage="None"/></s>
            <s sid="127">In our analyses among control women, individual <italic>GSTT1</italic>, <italic>GSTM1</italic>, <italic>GSTP1</italic>, and <italic>GSTA1</italic> genotypes were not associated with detectable PAH&#8211;DNA adducts, nor was the number of variant <italic>GST</italic> alleles.<CoreSc1 atype="GSC" type="Res" conceptID="Res28" novelty="None" advantage="None"/></s>
            <s sid="128">Even after stratification on smoking, the number of variant <italic>GST</italic> alleles was not associated with detectable PAH&#8211;DNA adducts; however, ever smokers with either the <italic>GSTM1</italic> null or <italic>GSTM1</italic> present genotype had a reduced risk of detectable PAH&#8211;DNA adducts (<xref ref-type="table" rid="t5-ehp-117-552">Table 5</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res29" novelty="None" advantage="None"/></s>
            <s sid="129">We observed a similar finding within the strata of ever smokers and the <italic>GSTP1</italic> common genotype compared with never smokers with the common genotype.<CoreSc1 atype="GSC" type="Res" conceptID="Res30" novelty="None" advantage="None"/></s>
            <s sid="130">Our results are the first published findings regarding <italic>GSTA1</italic> polymorphisms and PAH&#8211;DNA adducts.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj14" novelty="None" advantage="None"/></s>
            <s sid="131">Our findings related to polymorphisms in <italic>GSTM1</italic> and PAH&#8211;DNA adduct formation are in contrast with one study (<xref ref-type="bibr" rid="b49-ehp-117-552">Rundle et al. 2003</xref>), while being consistent with others that report no significant difference in detectable PAH&#8211;DNA adducts based on <italic>GSTM1</italic> status (<xref ref-type="bibr" rid="b23-ehp-117-552">Grinberg-Funes et al. 1994</xref>; <xref ref-type="bibr" rid="b47-ehp-117-552">Rothman et al. 1995</xref>; <xref ref-type="bibr" rid="b63-ehp-117-552">Weiserbs et al. 2003</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res31" novelty="None" advantage="None"/></s>
            <s sid="132">However, the LIBCSP results reported here are based upon a much larger sample size than previous analyses, which yields more stable effect estimates.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj15" novelty="None" advantage="None"/></s>
            <s sid="133">Additionally, we used different methods to measure the PAH&#8211;DNA adducts in the various studies, possibly influencing the results.<CoreSc1 atype="GSC" type="Met" conceptID="Met19" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Methodological considerations</title>
          <p>
            <s sid="134">In an epidemiologic study, the use of a biomarker of exposure, such as PAH&#8211;DNA adducts, is considered superior because exposure assessment is not based on self-report, eliminating concerns for recall bias.In an epidemiologic study, the use of a biomarker of exposure, such as PAH&#8211;DNA adducts, is considered superior because exposure assessment is not based on self-report, eliminating concerns for recall bias.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac32" novelty="None" advantage="None"/></s>
            <s sid="135">Reliability in the measurement of genotype and adducts was high.<CoreSc1 atype="GSC" type="Met" conceptID="Met20" novelty="None" advantage="None"/></s>
            <s sid="136">Measurement error was possible, although unlikely with genotyping and analysis of adducts; however, because the laboratory was blinded to status of samples, any measurement error in measuring genotype and of PAH&#8211;DNA adduct status was independent of case&#8211;control status.<CoreSc1 atype="GSC" type="Met" conceptID="Met21" novelty="None" advantage="None"/></s>
            <s sid="137">Therefore, any resulting bias would have been nondifferential.<CoreSc1 atype="GSC" type="Met" conceptID="Met22" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="138">Our study power was limited when we examined interactions within subgroups of women, such as those with PAH&#8211;DNA adducts.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot14" novelty="None" advantage="None"/></s>
            <s sid="139">However, the LIBCSP is the largest study conducted to date with information on PAH&#8211;DNA adducts with which to evaluate these associations, and thus our study power was better than that of previously reported studies.<CoreSc1 atype="GSC" type="Met" conceptID="Met23" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="140">We selected the <italic>GST</italic> polymorphisms because of their role in phase II metabolism, specifically metabolism of PAH-reactive intermediates.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot15" novelty="None" advantage="None"/></s>
            <s sid="141">Because PAH&#8211;DNA adducts may be related to inherited differences in the metabolism of PAHs, this pathway was hypothesized to be important in individual breast cancer susceptibility.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp5" novelty="None" advantage="None"/></s>
            <s sid="142"><italic>GSTP1</italic> and <italic>GSTM1</italic> have been shown to have a role in detoxification of PAH carcinogenic intermediates produced by cytochrome P450 in phase I metabolism (<xref ref-type="bibr" rid="b7-ehp-117-552">Butkiewicz et al. 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac33" novelty="None" advantage="None"/></s>
            <s sid="143"><italic>GSTT1</italic> and <italic>GSTA1</italic> have also been implicated in the metabolism of PAH intermediates (<xref ref-type="bibr" rid="b22-ehp-117-552">Garte et al. 2007</xref>; <xref ref-type="bibr" rid="b25-ehp-117-552">Hayes and Pulford, 1995</xref>; <xref ref-type="bibr" rid="b34-ehp-117-552">Korashy and El-Kadi 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac34" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p>
          <s sid="144">Our previous analyses have shown that breast cancer risk was modestly elevated in relation to PAH&#8211;DNA adducts (<xref ref-type="bibr" rid="b20-ehp-117-552">Gammon et al. 2002b</xref>, <xref ref-type="bibr" rid="b18-ehp-117-552">2004b</xref>), among certain subgroups of smokers (<xref ref-type="bibr" rid="b16-ehp-117-552">Gammon et al. 2004a</xref>), and among women with multiple variant alleles in <italic>GST</italic> genes (<xref ref-type="bibr" rid="b56-ehp-117-552">Steck et al. 2007b</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac35" novelty="None" advantage="None"/></s>
          <s sid="145">In this analysis, however, we did not find strong evidence for further elevation of breast cancer risk, either on a multiplicative or on an additive scale, when we considered the joint effect of multiple GSTs and PAHs (cigarette smoking or PAH&#8211;DNA adducts), despite the biologic plausibility of such an interaction.<CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
          <s sid="146">These findings are based upon the largest population-based study of breast cancer conducted to date with a biomarker of PAH exposure.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/></s>
          <s sid="147">Further study may be warranted incorporating other biologic measures of PAH metabolism.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot16" novelty="None" advantage="None"/></s>
        </p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn>
          <p>This work was supported in part by grants from the National Cancer Institute and the National Institutes of Environmental Health Sciences of the National Institutes of Health (grants CA/S66572, P30ES10126, P30ES009089, 1K07CA102640, 5T32CA 009330, and L30 CA124219-01).</p>
        </fn>
      </fn-group>
      <ref-list>
        <title>References</title>
        <ref id="b1-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ahn</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Gammon</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Santella</surname>
                <given-names>RM</given-names>
              </name>
              <name name-style="western">
                <surname>Gaudet</surname>
                <given-names>MM</given-names>
              </name>
              <name name-style="western">
                <surname>Britton</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Teitelbaum</surname>
                <given-names>SL</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2006</year>
            <article-title>Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk</article-title>
            <source>Carcinogenesis</source>
            <volume>9</volume>
            <fpage>1876</fpage>
            <lpage>1882</lpage>
          </citation>
        </ref>
        <ref id="b2-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ambrosone</surname>
                <given-names>CB</given-names>
              </name>
              <name name-style="western">
                <surname>Freudenheim</surname>
                <given-names>JL</given-names>
              </name>
              <name name-style="western">
                <surname>Graham</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Marshall</surname>
                <given-names>JR</given-names>
              </name>
              <name name-style="western">
                <surname>Vena</surname>
                <given-names>JE</given-names>
              </name>
              <name name-style="western">
                <surname>Brasure</surname>
                <given-names>JR</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1995</year>
            <article-title>Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk</article-title>
            <source>Cancer Res</source>
            <volume>55</volume>
            <issue>16</issue>
            <fpage>3483</fpage>
            <lpage>3485</lpage>
          </citation>
        </ref>
        <ref id="b3-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Assmann</surname>
                <given-names>SF</given-names>
              </name>
              <name name-style="western">
                <surname>Hosmer</surname>
                <given-names>DW</given-names>
              </name>
              <name name-style="western">
                <surname>Lemeshow</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Mundt</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <year>1996</year>
            <article-title>Confidence intervals for measures of interaction</article-title>
            <source>Epidemiology</source>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>286</fpage>
            <lpage>290</lpage>
          </citation>
        </ref>
        <ref id="b4-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bell</surname>
                <given-names>DA</given-names>
              </name>
              <name name-style="western">
                <surname>Thompson</surname>
                <given-names>CL</given-names>
              </name>
              <name name-style="western">
                <surname>Taylor</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Miller</surname>
                <given-names>CR</given-names>
              </name>
              <name name-style="western">
                <surname>Perera</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Hsieh</surname>
                <given-names>LL</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1992</year>
            <article-title>Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu</article-title>
            <source>Environ Health Perspect</source>
            <volume>98</volume>
            <fpage>113</fpage>
            <lpage>117</lpage>
          </citation>
        </ref>
        <ref id="b5-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Boffetta</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Jourenkova</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Gustavsson</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <year>1997</year>
            <article-title>Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons</article-title>
            <source>Cancer Causes Control</source>
            <volume>8</volume>
            <fpage>444</fpage>
            <lpage>472</lpage>
          </citation>
        </ref>
        <ref id="b6-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Brescia</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Celotti</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Clonfero</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Neumann</surname>
                <given-names>GH</given-names>
              </name>
              <name name-style="western">
                <surname>Forni</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Foa</surname>
                <given-names>V</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2004</year>
            <article-title>The influence of cytochrome P450 1A1 and glutathione S-transferase M1 genotypes on biomarker levels in coke-oven workers</article-title>
            <source>Arch Toxicol</source>
            <volume>73</volume>
            <fpage>431</fpage>
            <lpage>439</lpage>
          </citation>
        </ref>
        <ref id="b7-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Butkiewicz</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Grzybowska</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Phillips</surname>
                <given-names>DH</given-names>
              </name>
              <name name-style="western">
                <surname>Hemminki</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Chorazy</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells</article-title>
            <source>Environ Mol Mutagen</source>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <lpage>105</lpage>
          </citation>
        </ref>
        <ref id="b8-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cavalieri</surname>
                <given-names>EL</given-names>
              </name>
              <name name-style="western">
                <surname>Higginbotham</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>RamaKrishna</surname>
                <given-names>KNVS</given-names>
              </name>
              <name name-style="western">
                <surname>Devanesan</surname>
                <given-names>PD</given-names>
              </name>
              <name name-style="western">
                <surname>Todorovic</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Rogan</surname>
                <given-names>EG</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1991</year>
            <article-title>Comparative dose&#8211;response tumorigenicity studies of dibenzo[<italic>a,l</italic>]pyrene versus 7,12-dimethylbenz[<italic>a</italic>]anthracene, benzo[<italic>a</italic>]pyrene and two dibenzo[<italic>a,l</italic>]pyrene dihydrodiols in mouse skin and rat mammary gland</article-title>
            <source>Carcinogenesis</source>
            <volume>10</volume>
            <fpage>1939</fpage>
            <lpage>1944</lpage>
          </citation>
        </ref>
        <ref id="b9-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Coles</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Nowell</surname>
                <given-names>SA</given-names>
              </name>
              <name name-style="western">
                <surname>MacLeod</surname>
                <given-names>SL</given-names>
              </name>
              <name name-style="western">
                <surname>Sweeny</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Lang</surname>
                <given-names>NP</given-names>
              </name>
              <name name-style="western">
                <surname>Kadlubar</surname>
                <given-names>FF</given-names>
              </name>
            </person-group>
            <year>2001b</year>
            <article-title>The role of human glutathione <italic>S</italic>-transferases (hGSTs) in the detoxification of food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk</article-title>
            <source>Mutat Res</source>
            <volume>482</volume>
            <fpage>3</fpage>
            <lpage>10</lpage>
          </citation>
        </ref>
        <ref id="b10-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Coles</surname>
                <given-names>BF</given-names>
              </name>
              <name name-style="western">
                <surname>Kadlubar</surname>
                <given-names>FF</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Detoxification of electrophilic compounds by glutathione <italic>S</italic>-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?</article-title>
            <source>Biofactors</source>
            <volume>17</volume>
            <fpage>115</fpage>
            <lpage>130</lpage>
          </citation>
        </ref>
        <ref id="b11-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Coles</surname>
                <given-names>BF</given-names>
              </name>
              <name name-style="western">
                <surname>Kadlubar</surname>
                <given-names>FF</given-names>
              </name>
              <name name-style="western">
                <surname>Sies</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Packer</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Human alpha class glutathione <italic>S</italic>-transferases: genetic polymorphism, expression, and susceptibility to disease</article-title>
            <source>Methods Enzymol</source>
            <volume>401</volume>
            <fpage>9</fpage>
            <lpage>42</lpage>
          </citation>
        </ref>
        <ref id="b12-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Coles</surname>
                <given-names>BF</given-names>
              </name>
              <name name-style="western">
                <surname>Morel</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Rauch</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Huber</surname>
                <given-names>WW</given-names>
              </name>
              <name name-style="western">
                <surname>Yang</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Teitel</surname>
                <given-names>CH</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2001a</year>
            <article-title>Effect of polymorphism in the human glutathione <italic>S</italic>-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression</article-title>
            <source>Pharmacogenetics</source>
            <volume>11</volume>
            <fpage>663</fpage>
            <lpage>669</lpage>
          </citation>
        </ref>
        <ref id="b13-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>el-Bayoumy</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Chae</surname>
                <given-names>YH</given-names>
              </name>
              <name name-style="western">
                <surname>Upadhyaya</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Rivenson</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Kurtzke</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Reddy</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <year>1995</year>
            <article-title>Comparative tumorigenicity of benzo[a]pyrene, 1-nitropyrene and 2-amino-1-methyl-6-phenylimidazo[4,5-<italic>b</italic>]pyridine administered by gavage to female CD rats</article-title>
            <source>Carcinogenesis</source>
            <volume>16</volume>
            <fpage>431</fpage>
            <lpage>434</lpage>
          </citation>
        </ref>
        <ref id="b14-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Fannon</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>Single nucleotide polymorphism (SNP) analysis of a variety of non-ideal DNA sample types by SEQUENOM MassARRAY matrix assisted laser desorption/ionization time of flight (MALDI-TOF)</article-title>
            <source>Proc Am Assoc Cancer Res</source>
            <volume>43</volume>
            <fpage>53</fpage>
          </citation>
        </ref>
        <ref id="b15-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Fields</surname>
                <given-names>WR</given-names>
              </name>
              <name name-style="western">
                <surname>Morrow</surname>
                <given-names>CS</given-names>
              </name>
              <name name-style="western">
                <surname>Doss</surname>
                <given-names>AJ</given-names>
              </name>
              <name name-style="western">
                <surname>Sundberg</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Jernstr&#246;m</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Townsend</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <year>1998</year>
            <article-title>Overexpression of stably transfected human glutathione <italic>S</italic>-transferase P1-1 protects against DNA damage by benzo[<italic>a</italic>]pyrene diolepoxide in human T47D cells</article-title>
            <source>Mol Pharmacol</source>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>298</fpage>
            <lpage>304</lpage>
          </citation>
        </ref>
        <ref id="b16-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gammon</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Eng</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Teitelbaum</surname>
                <given-names>SL</given-names>
              </name>
              <name name-style="western">
                <surname>Britton</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Kabat</surname>
                <given-names>GC</given-names>
              </name>
              <name name-style="western">
                <surname>Hatch</surname>
                <given-names>M</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2004a</year>
            <article-title>Environmental tobacco smoke and breast cancer incidence</article-title>
            <source>Environ Res</source>
            <volume>96</volume>
            <issue>2</issue>
            <fpage>176</fpage>
            <lpage>185</lpage>
          </citation>
        </ref>
        <ref id="b17-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gammon</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Neugut</surname>
                <given-names>AI</given-names>
              </name>
              <name name-style="western">
                <surname>Santella</surname>
                <given-names>RM</given-names>
              </name>
              <name name-style="western">
                <surname>Teitelbaum</surname>
                <given-names>SL</given-names>
              </name>
              <name name-style="western">
                <surname>Britton</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Terry</surname>
                <given-names>MB</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2002a</year>
            <article-title>The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer</article-title>
            <source>Breast Cancer Res Treat</source>
            <volume>74</volume>
            <fpage>235</fpage>
            <lpage>254</lpage>
          </citation>
        </ref>
        <ref id="b18-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gammon</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Sagiv</surname>
                <given-names>SK</given-names>
              </name>
              <name name-style="western">
                <surname>Eng</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Shantakumar</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Gaudet</surname>
                <given-names>MM</given-names>
              </name>
              <name name-style="western">
                <surname>Teitelbaum</surname>
                <given-names>SL</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2004b</year>
            <article-title>Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis</article-title>
            <source>Arch Environ Health</source>
            <volume>59</volume>
            <fpage>640</fpage>
            <lpage>649</lpage>
          </citation>
        </ref>
        <ref id="b19-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gammon</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Santella</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <year>2008</year>
            <article-title>PAH, genetic susceptibility, and breast cancer risk: an update from the Long Island Breast Cancer Study Project</article-title>
            <source>Eur J Cancer</source>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>636</fpage>
            <lpage>640</lpage>
          </citation>
        </ref>
        <ref id="b20-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gammon</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Santella</surname>
                <given-names>RM</given-names>
              </name>
              <name name-style="western">
                <surname>Neugut</surname>
                <given-names>AI</given-names>
              </name>
              <name name-style="western">
                <surname>Eng</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Teitelbaum</surname>
                <given-names>SL</given-names>
              </name>
              <name name-style="western">
                <surname>Paykin</surname>
                <given-names>A</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2002b</year>
            <article-title>Environmental Toxins and Breast Cancer on Long Island I. Polycyclic aromatic hydrocarbon DNA adducts</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>11</volume>
            <fpage>677</fpage>
            <lpage>685</lpage>
          </citation>
        </ref>
        <ref id="b21-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Garc&#237;a-Closas</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Kelsey</surname>
                <given-names>KT</given-names>
              </name>
              <name name-style="western">
                <surname>Hankinson</surname>
                <given-names>SE</given-names>
              </name>
              <name name-style="western">
                <surname>Spiegelman</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Springer</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Willett</surname>
                <given-names>WC</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1999</year>
            <article-title>Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>91</volume>
            <issue>22</issue>
            <fpage>1960</fpage>
            <lpage>1964</lpage>
          </citation>
        </ref>
        <ref id="b22-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Garte</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Taioli</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Popov</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>Kalina</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Sram</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Farmer</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Role of GSTT1 deletion in DNA oxidative damage by exposure to polycyclic aromatic hydrocarbons in humans</article-title>
            <source>Int J Cancer</source>
            <volume>120</volume>
            <issue>11</issue>
            <fpage>2499</fpage>
            <lpage>2503</lpage>
          </citation>
        </ref>
        <ref id="b23-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Grinberg-Funes</surname>
                <given-names>RA</given-names>
              </name>
              <name name-style="western">
                <surname>Singh</surname>
                <given-names>VN</given-names>
              </name>
              <name name-style="western">
                <surname>Perera</surname>
                <given-names>FP</given-names>
              </name>
              <name name-style="western">
                <surname>Bell</surname>
                <given-names>DA</given-names>
              </name>
              <name name-style="western">
                <surname>Young</surname>
                <given-names>TL</given-names>
              </name>
              <name name-style="western">
                <surname>Dickey</surname>
                <given-names>C</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1994</year>
            <article-title>Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-<italic>S</italic>-transferase M1 genotype</article-title>
            <source>Carcinogenesis</source>
            <volume>15</volume>
            <issue>11</issue>
            <fpage>2449</fpage>
            <lpage>2454</lpage>
          </citation>
        </ref>
        <ref id="b24-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hatsukami</surname>
                <given-names>DK</given-names>
              </name>
              <name name-style="western">
                <surname>Benowitz</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Rennard</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Oncken</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Biomarkers to assess the utility of potential reduced exposure tobacco products</article-title>
            <source>Nicotine Tob Res</source>
            <volume>8</volume>
            <fpage>599</fpage>
            <lpage>622</lpage>
          </citation>
        </ref>
        <ref id="b25-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hayes</surname>
                <given-names>JD</given-names>
              </name>
              <name name-style="western">
                <surname>Pulford</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <year>1995</year>
            <article-title>The glutathione <italic>S</italic>-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance</article-title>
            <source>Crit Rev Biochem Mol Biol</source>
            <volume>30</volume>
            <fpage>445</fpage>
            <lpage>600</lpage>
          </citation>
        </ref>
        <ref id="b26-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <year>1996</year>
            <article-title>Chemoprevention of lung cancer by isothiocyanates</article-title>
            <source>Adv Exp Med Biol</source>
            <volume>401</volume>
            <fpage>1</fpage>
            <lpage>11</lpage>
          </citation>
        </ref>
        <ref id="b27-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <year>1999</year>
            <article-title>Tobacco smoke carcinogens and lung cancer</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>91</volume>
            <issue>14</issue>
            <fpage>1194</fpage>
            <lpage>1210</lpage>
          </citation>
        </ref>
        <ref id="b28-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Inhibition of carcinogenesis by isothiocyanates</article-title>
            <source>Drug Metab Rev</source>
            <volume>32</volume>
            <issue>3&#8211;4</issue>
            <fpage>395</fpage>
            <lpage>411</lpage>
          </citation>
        </ref>
        <ref id="b29-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Tobacco carcinogens, their biomarkers, and tobacco induced cancer</article-title>
            <source>Nature Rev Cancer</source>
            <volume>3</volume>
            <fpage>733</fpage>
            <lpage>744</lpage>
          </citation>
        </ref>
        <ref id="b30-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>SS</given-names>
              </name>
              <name name-style="western">
                <surname>Carmella</surname>
                <given-names>SG</given-names>
              </name>
              <name name-style="western">
                <surname>Yoder</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Le</surname>
                <given-names>C</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2006</year>
            <article-title>Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers</article-title>
            <source>Cancer Epidemiol Biomarker Prev</source>
            <volume>15</volume>
            <fpage>1805</fpage>
            <lpage>1811</lpage>
          </citation>
        </ref>
        <ref id="b31-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Helzlsouer</surname>
                <given-names>KJ</given-names>
              </name>
              <name name-style="western">
                <surname>Selmin</surname>
                <given-names>O</given-names>
              </name>
              <name name-style="western">
                <surname>Huang</surname>
                <given-names>HY</given-names>
              </name>
              <name name-style="western">
                <surname>Strickland</surname>
                <given-names>PT</given-names>
              </name>
              <name name-style="western">
                <surname>Hoffman</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Alberg</surname>
                <given-names>AJ</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1998</year>
            <article-title>Association between glutathione <italic>S</italic>-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>90</volume>
            <issue>7</issue>
            <fpage>512</fpage>
            <lpage>518</lpage>
          </citation>
        </ref>
        <ref id="b32-ehp-117-552">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hosmer</surname>
                <given-names>DW</given-names>
              </name>
              <name name-style="western">
                <surname>Lemeshow</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <year>1989</year>
            <source>Applied Logistic Regression</source>
            <publisher-loc>New York</publisher-loc>
            <publisher-name>John Wiley and Sons</publisher-name>
          </citation>
        </ref>
        <ref id="b33-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hu</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Li</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Xue</surname>
                <given-names>X</given-names>
              </name>
              <name name-style="western">
                <surname>Zhou</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name name-style="western">
                <surname>Fu</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>PAH-DNA adducts in a Chinese population: relationship to PAH exposure, smoking, and polymorphisms of metabolic and DNA repair genes</article-title>
            <source>Biomarkers</source>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <lpage>40</lpage>
          </citation>
        </ref>
        <ref id="b34-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Korashy</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>El-Kadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases</article-title>
            <source>Drug Metab Rev</source>
            <volume>38</volume>
            <fpage>411</fpage>
            <lpage>450</lpage>
          </citation>
        </ref>
        <ref id="b35-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kuljukka-Rabb</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>Nylund</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Vaaranrinta</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Savela</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Mutanene</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Veidebaum</surname>
                <given-names>T</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2002</year>
            <article-title>The effect of relevant genotypes on PAH exposure-related biomarkers</article-title>
            <source>J Expo Anal Environ Epidemiol</source>
            <volume>12</volume>
            <fpage>89</fpage>
            <lpage>91</lpage>
          </citation>
        </ref>
        <ref id="b36-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Walcott</surname>
                <given-names>FL</given-names>
              </name>
              <name name-style="western">
                <surname>Chang</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name name-style="western">
                <surname>Zhu</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Petrulis</surname>
                <given-names>E</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2002</year>
            <article-title>Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer</article-title>
            <source>Cancer Res</source>
            <volume>62</volume>
            <fpage>4566</fpage>
            <lpage>4570</lpage>
          </citation>
        </ref>
        <ref id="b37-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Dhingra</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Hittelman</surname>
                <given-names>WN</given-names>
              </name>
            </person-group>
            <year>1996</year>
            <article-title>Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology</article-title>
            <source>Cancer Res</source>
            <volume>56</volume>
            <fpage>287</fpage>
            <lpage>293</lpage>
          </citation>
        </ref>
        <ref id="b38-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lioy</surname>
                <given-names>PJ</given-names>
              </name>
              <name name-style="western">
                <surname>Greenberg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>1990</year>
            <article-title>Factors associated with human exposures to polycyclic aromatic hydrocarbons</article-title>
            <source>Toxicol Ind Health</source>
            <volume>6</volume>
            <fpage>209</fpage>
            <lpage>223</lpage>
          </citation>
        </ref>
        <ref id="b39-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Millikan</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Pittman</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Tse</surname>
                <given-names>CK</given-names>
              </name>
              <name name-style="western">
                <surname>Savitz</surname>
                <given-names>DA</given-names>
              </name>
              <name name-style="western">
                <surname>Newman</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Bell</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Glutathione <italic>S</italic>-transferases M1, T1, and P1 and breast cancer</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>567</fpage>
            <lpage>573</lpage>
          </citation>
        </ref>
        <ref id="b40-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mitrunen</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Hirvonen</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Molecular epidemiology of sporadic breast cancer: the role of polymorphic genes involved in oestrogen biosynthesis and metabolism</article-title>
            <source>Mutat Res</source>
            <volume>544</volume>
            <fpage>9</fpage>
            <lpage>41</lpage>
          </citation>
        </ref>
        <ref id="b41-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Nakajima</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>Elovaara</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Anttila</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Hirvonen</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Camus</surname>
                <given-names>AM</given-names>
              </name>
              <name name-style="western">
                <surname>Hayes</surname>
                <given-names>JD</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1995</year>
            <article-title>Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer</article-title>
            <source>Carcinogenesis</source>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>707</fpage>
            <lpage>711</lpage>
          </citation>
        </ref>
        <ref id="b42-ehp-117-552">
          <citation citation-type="web" xlink:type="simple">
            <collab xlink:type="simple">NCBI (National Center for Biotechnology Information)</collab>
            <year>2009a</year>
            <source>GenBank Overview</source>
            <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Genbank/" xlink:type="simple">http://www.ncbi.nlm.nih.gov/Genbank/</ext-link></comment>
            <access-date>[accessed 10 March 2009]</access-date>
          </citation>
        </ref>
        <ref id="b43-ehp-117-552">
          <citation citation-type="web" xlink:type="simple">
            <collab xlink:type="simple">NCBI (National Center for Biotechnology Information)</collab>
            <year>2009b</year>
            <source>UniGene</source>
            <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/unigene" xlink:type="simple">http://www.ncbi.nlm.nih.gov/unigene</ext-link></comment>
            <access-date>[accessed 10 March 2009]</access-date>
          </citation>
        </ref>
        <ref id="b44-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Pavanello</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Clonfero</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Biological indicators of genotoxic risk and metabolic polymorphisms</article-title>
            <source>Mutat Res</source>
            <volume>463</volume>
            <fpage>285</fpage>
            <lpage>308</lpage>
          </citation>
        </ref>
        <ref id="b45-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Pelin</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Hirvonen</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Norppa</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <year>1996</year>
            <article-title>Influence of erythrocyte glutathione-S transferase T1 on sister chromatid exchanges induced by diepoxybutane in cultured human lymphocytes</article-title>
            <source>Mutagenesis</source>
            <volume>11</volume>
            <fpage>213</fpage>
            <lpage>215</lpage>
          </citation>
        </ref>
        <ref id="b46-ehp-117-552">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rothman</surname>
                <given-names>KJ</given-names>
              </name>
              <name name-style="western">
                <surname>Greenland</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <year>1998</year>
            <source>Modern Epidemiology</source>
            <publisher-loc>Philadelphia</publisher-loc>
            <publisher-name>Lippincott-Raven Publishers</publisher-name>
          </citation>
        </ref>
        <ref id="b47-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rothman</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Shields</surname>
                <given-names>PG</given-names>
              </name>
              <name name-style="western">
                <surname>Poirier</surname>
                <given-names>MC</given-names>
              </name>
              <name name-style="western">
                <surname>Harrington</surname>
                <given-names>AM</given-names>
              </name>
              <name name-style="western">
                <surname>Ford</surname>
                <given-names>DP</given-names>
              </name>
              <name name-style="western">
                <surname>Strickland</surname>
                <given-names>PT</given-names>
              </name>
            </person-group>
            <year>1995</year>
            <article-title>The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans</article-title>
            <source>Mol Carcinog</source>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <lpage>68</lpage>
          </citation>
        </ref>
        <ref id="b48-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rundle</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Tang</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Hibshoosh</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Estabrook</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Schnabel</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Cao</surname>
                <given-names>W</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2000a</year>
            <article-title>The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer</article-title>
            <source>Carcinogenesis</source>
            <volume>21</volume>
            <fpage>1281</fpage>
            <lpage>1289</lpage>
          </citation>
        </ref>
        <ref id="b49-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rundle</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Tang</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Mooney</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Grumet</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Perera</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>The interaction between alcohol consumption and GSTM1 genotype on polycyclic aromatic hydrocarbon-DNA adduct levels in breast tissue</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>12</volume>
            <issue>9</issue>
            <fpage>911</fpage>
            <lpage>914</lpage>
          </citation>
        </ref>
        <ref id="b50-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rundle</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Tang</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Zhou</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Cho</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Perera</surname>
                <given-names>FP</given-names>
              </name>
            </person-group>
            <year>2000b</year>
            <article-title>The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>9</volume>
            <fpage>1079</fpage>
            <lpage>1085</lpage>
          </citation>
        </ref>
        <ref id="b51-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ryberg</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Skaug</surname>
                <given-names>V</given-names>
              </name>
              <name name-style="western">
                <surname>Hewer</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Philips</surname>
                <given-names>DH</given-names>
              </name>
              <name name-style="western">
                <surname>Harries</surname>
                <given-names>LW</given-names>
              </name>
              <name name-style="western">
                <surname>Wolf</surname>
                <given-names>CR</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1997</year>
            <article-title>Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk</article-title>
            <source>Carcinogenesis</source>
            <volume>18</volume>
            <fpage>1285</fpage>
            <lpage>1289</lpage>
          </citation>
        </ref>
        <ref id="b52-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Shantakumar</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Gammon</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Eng</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Sagiv</surname>
                <given-names>SK</given-names>
              </name>
              <name name-style="western">
                <surname>Gaudet</surname>
                <given-names>MM</given-names>
              </name>
              <name name-style="western">
                <surname>Teitelbaum</surname>
                <given-names>SL</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females</article-title>
            <source>J Expo Anal Environ Epidemiol</source>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>482</fpage>
            <lpage>490</lpage>
          </citation>
        </ref>
        <ref id="b53-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Shimada</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Xenobiotic-metabolizing enzymes involved in the activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons</article-title>
            <source>Drug Metab Pharmacokinet</source>
            <volume>24</volume>
            <fpage>257</fpage>
            <lpage>276</lpage>
          </citation>
        </ref>
        <ref id="b54-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Spurdle</surname>
                <given-names>AB</given-names>
              </name>
              <name name-style="western">
                <surname>Chang</surname>
                <given-names>JH</given-names>
              </name>
              <name name-style="western">
                <surname>Byrnes</surname>
                <given-names>GB</given-names>
              </name>
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name name-style="western">
                <surname>Dite</surname>
                <given-names>GS</given-names>
              </name>
              <name name-style="western">
                <surname>McCredie</surname>
                <given-names>MR</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>A systematic approach to analyzing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>769</fpage>
            <lpage>774</lpage>
          </citation>
        </ref>
        <ref id="b55-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Steck</surname>
                <given-names>SE</given-names>
              </name>
              <name name-style="western">
                <surname>Gammon</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Hebert</surname>
                <given-names>JR</given-names>
              </name>
              <name name-style="western">
                <surname>Wall</surname>
                <given-names>DE</given-names>
              </name>
              <name name-style="western">
                <surname>Zeisel</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <year>2007a</year>
            <article-title>GSTM1, GSTT1, GSTP1, and GSTA1 polymorphisms and urinary isothiocyanate metabolites following broccoli consumption in humans</article-title>
            <source>J Nutr</source>
            <volume>137</volume>
            <issue>4</issue>
            <fpage>904</fpage>
            <lpage>909</lpage>
          </citation>
        </ref>
        <ref id="b56-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Steck</surname>
                <given-names>SE</given-names>
              </name>
              <name name-style="western">
                <surname>Gaudet</surname>
                <given-names>MM</given-names>
              </name>
              <name name-style="western">
                <surname>Britton</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Teitelbaum</surname>
                <given-names>SL</given-names>
              </name>
              <name name-style="western">
                <surname>Terry</surname>
                <given-names>MB</given-names>
              </name>
              <name name-style="western">
                <surname>Neugut</surname>
                <given-names>AI</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007b</year>
            <article-title>Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk</article-title>
            <source>Carcinogenesis</source>
            <volume>28</volume>
            <issue>9</issue>
            <fpage>1954</fpage>
            <lpage>1959</lpage>
          </citation>
        </ref>
        <ref id="b57-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Terry</surname>
                <given-names>PD</given-names>
              </name>
              <name name-style="western">
                <surname>Goodman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>602</fpage>
            <lpage>611</lpage>
          </citation>
        </ref>
        <ref id="b58-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Upadhyaya</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Rao</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Hochalter</surname>
                <given-names>JB</given-names>
              </name>
              <name name-style="western">
                <surname>Li</surname>
                <given-names>ZZ</given-names>
              </name>
              <name name-style="western">
                <surname>Villalta</surname>
                <given-names>PW</given-names>
              </name>
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Quantitation of N-acetyl-S-(9,10-dihydro-9-hydroxy-10-phenanthryl)-L-cysteine in human urine: comparison of glutathione-S-transferase genotypes in smokers</article-title>
            <source>Chem Res Toxicol</source>
            <volume>19</volume>
            <fpage>1234</fpage>
            <lpage>1240</lpage>
          </citation>
        </ref>
        <ref id="b59-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>van der Hel</surname>
                <given-names>OL</given-names>
              </name>
              <name name-style="western">
                <surname>Bueno-de-Mesquita</surname>
                <given-names>HB</given-names>
              </name>
              <name name-style="western">
                <surname>van Gils</surname>
                <given-names>CH</given-names>
              </name>
              <name name-style="western">
                <surname>Roest</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Slothouber</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Grobbee</surname>
                <given-names>DE</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands)</article-title>
            <source>Cancer Causes Control</source>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>675</fpage>
            <lpage>681</lpage>
          </citation>
        </ref>
        <ref id="b60-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Vogl</surname>
                <given-names>FD</given-names>
              </name>
              <name name-style="western">
                <surname>Taioli</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Maugard</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Zheng</surname>
                <given-names>W</given-names>
              </name>
              <name name-style="western">
                <surname>Pinto</surname>
                <given-names>LF</given-names>
              </name>
              <name name-style="western">
                <surname>Ambrosone</surname>
                <given-names>C</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2004</year>
            <article-title>Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>13</volume>
            <issue>9</issue>
            <fpage>1473</fpage>
            <lpage>1479</lpage>
          </citation>
        </ref>
        <ref id="b61-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Waldman</surname>
                <given-names>JM</given-names>
              </name>
              <name name-style="western">
                <surname>Lioy</surname>
                <given-names>PJ</given-names>
              </name>
              <name name-style="western">
                <surname>Greenberg</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Butler</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <year>1991</year>
            <article-title>Analysis of human exposure to benzo(<italic>a</italic>)pyrene via inhalation and food ingestion in the Total Human Environmental Exposure Study (THEES)</article-title>
            <source>J Expo Anal Environ Epidemiol</source>
            <volume>1</volume>
            <fpage>193</fpage>
            <lpage>225</lpage>
          </citation>
        </ref>
        <ref id="b62-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Watson</surname>
                <given-names>MA</given-names>
              </name>
              <name name-style="western">
                <surname>Stewart</surname>
                <given-names>RK</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>GB</given-names>
              </name>
              <name name-style="western">
                <surname>Massey</surname>
                <given-names>TE</given-names>
              </name>
              <name name-style="western">
                <surname>Bell</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <year>1998</year>
            <article-title>Human glutathione S-transferase P1 polymorphism: relationship to lung tissue enzyme activity and population frequency distribution</article-title>
            <source>Carcinogenesis</source>
            <volume>19</volume>
            <fpage>275</fpage>
            <lpage>280</lpage>
          </citation>
        </ref>
        <ref id="b63-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Weiserbs</surname>
                <given-names>KF</given-names>
              </name>
              <name name-style="western">
                <surname>Jacobson</surname>
                <given-names>JS</given-names>
              </name>
              <name name-style="western">
                <surname>Begg</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>LW</given-names>
              </name>
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name name-style="western">
                <surname>Agrawal</surname>
                <given-names>M</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2003</year>
            <article-title>A cross-sectional study of polycyclic aromatic hydrocarbon-DNA adducts and polymorphism of glutathione S-transferases among heavy smokers by race/ethnicity</article-title>
            <source>Biomarkers</source>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>142</fpage>
            <lpage>155</lpage>
          </citation>
        </ref>
        <ref id="b64-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wogan</surname>
                <given-names>GM</given-names>
              </name>
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>SS</given-names>
              </name>
              <name name-style="western">
                <surname>Felton</surname>
                <given-names>JS</given-names>
              </name>
              <name name-style="western">
                <surname>Conney</surname>
                <given-names>AH</given-names>
              </name>
              <name name-style="western">
                <surname>Loeb</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <year>2004</year>
            <article-title>Environmental and chemical carcinogenesis</article-title>
            <source>Semin Cancer Biol</source>
            <volume>14</volume>
            <fpage>473</fpage>
            <lpage>486</lpage>
          </citation>
        </ref>
        <ref id="b65-ehp-117-552">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Zheng</surname>
                <given-names>W</given-names>
              </name>
              <name name-style="western">
                <surname>Wen</surname>
                <given-names>WQ</given-names>
              </name>
              <name name-style="western">
                <surname>Gustafson</surname>
                <given-names>DR</given-names>
              </name>
              <name name-style="western">
                <surname>Gross</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Cerhan</surname>
                <given-names>JR</given-names>
              </name>
              <name name-style="western">
                <surname>Folsom</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>GSTM1 and GSTT1 polymorphisms and post-menopausal breast cancer risk</article-title>
            <source>Breast Cancer Res Treat</source>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <lpage>16</lpage>
          </citation>
        </ref>
      </ref-list>
    </back>
  </article>
</PAPER>